66 related articles for article (PubMed ID: 265651)
1. [Systemic manifestations in rheumatoid arthritis. A multivariate analysis of 122 patients (author's transl)].
Kolarz G
Wien Klin Wochenschr Suppl; 1977; 68():1-19. PubMed ID: 265651
[TBL] [Abstract][Full Text] [Related]
2. Rheumatoid factor by laser nephelometry and Waaler-Rose assay: prognostic value in patients with recent-onset rheumatoid arthritis.
Nikolaisen C; Rekvig OP; Nossent HC
Scand J Rheumatol; 2005; 34(4):269-76. PubMed ID: 16195159
[TBL] [Abstract][Full Text] [Related]
3. The photometric latex test for rheumatoid factors in patients with rheumatoid arthritis. II. Clinical evaluation.
Dezelić G; Dürrigl T; Dezelić N; Zergollern V; Jurak H; Vitaus M; Androić S
Z Rheumatol; 1978; 37(3-4):112-22. PubMed ID: 636666
[TBL] [Abstract][Full Text] [Related]
4. [Sulfhydril groups in sera of patients with rheumatoid arthritis (author's transl)].
Brmcír Z; Salavec M; Tichý M
Cas Lek Cesk; 1975 Mar; 114(12):356-9. PubMed ID: 1139585
[No Abstract] [Full Text] [Related]
5. [Progression of rheumatoid arthritis].
Keitel W; Uhle R
Z Gesamte Inn Med; 1976 Jul; 31(13):490-3. PubMed ID: 960871
[TBL] [Abstract][Full Text] [Related]
6. Autoantibodies in early seropositive rheumatoid arthritis, before and during disease modifying antirheumatic drug treatment.
Paulus HE; Wiesner J; Bulpitt KJ; Patnaik M; Law J; Park GS; Wong WK
J Rheumatol; 2002 Dec; 29(12):2513-20. PubMed ID: 12465144
[TBL] [Abstract][Full Text] [Related]
7. [Reumatoid factor in the synovial fluid in reumatoid arthritis. Relations to serum findings, age, sex, duration and stage of the disease (author's transl)].
Hrncír Z; Salavec M; Tichý M
Cas Lek Cesk; 1975 Jan; 114(3):79-82. PubMed ID: 1120322
[No Abstract] [Full Text] [Related]
8. Anti-CCP2 is an adjunct to, not a surrogate for, rheumatoid factor in the diagnosis of rheumatoid arthritis: diagnostic utility of anti-CCP2 antibodies in Egyptian patients with rheumatoid arthritis.
Abdel-Nasser AM; Mahmoud MH; El Mansoury TM; Osman AM
Scand J Rheumatol; 2008; 37(5):329-36. PubMed ID: 18666028
[TBL] [Abstract][Full Text] [Related]
9. Prognostic factors for the development of rheumatoid arthritis and other connective tissue diseases in patients with palindromic rheumatism.
Gonzalez-Lopez L; Gamez-Nava JI; Jhangri GS; Ramos-Remus C; Russell AS; Suarez-Almazor ME
J Rheumatol; 1999 Mar; 26(3):540-5. PubMed ID: 10090159
[TBL] [Abstract][Full Text] [Related]
10. [Rheumatoid arthritis with systemic manifestations: its diagnosis and clinical aspects].
Nasonova VA; Alekberova ZS; Saĭkovskii RS; Balabanova RM; Kotel'nikova GP
Ter Arkh; 1988; 60(7):98-103. PubMed ID: 3212748
[TBL] [Abstract][Full Text] [Related]
11. [High titers of rheumatoid factor: clinical significance].
Naranjo Hernández A; Rodríguez González T; Rodríguez-Lozano C; Ojeda Bruno S; Francisco Hernández F; Sánchez-García F; Bilbao Cantarero A
Rev Clin Esp; 1997 Apr; 197(4):232-6. PubMed ID: 9254397
[TBL] [Abstract][Full Text] [Related]
12. IgG, IgA, IgM antibodies to a viral citrullinated peptide in patients affected by rheumatoid arthritis, chronic arthritides and connective tissue disorders.
Anzilotti C; Riente L; Pratesi F; Chimenti D; Delle Sedie A; Bombardieri S; Migliorini P
Rheumatology (Oxford); 2007 Oct; 46(10):1579-82. PubMed ID: 17717033
[TBL] [Abstract][Full Text] [Related]
13. Value of anti-modified citrullinated vimentin and third-generation anti-cyclic citrullinated peptide compared with second-generation anti-cyclic citrullinated peptide and rheumatoid factor in predicting disease outcome in undifferentiated arthritis and rheumatoid arthritis.
van der Linden MP; van der Woude D; Ioan-Facsinay A; Levarht EW; Stoeken-Rijsbergen G; Huizinga TW; Toes RE; van der Helm-van Mil AH
Arthritis Rheum; 2009 Aug; 60(8):2232-41. PubMed ID: 19644872
[TBL] [Abstract][Full Text] [Related]
14. A clinical study of older age rheumatoid arthritis with comparison to a younger onset group.
Terkeltaub R; Esdaile J; Décary F; Tannenbaum H
J Rheumatol; 1983 Jun; 10(3):418-24. PubMed ID: 6411919
[TBL] [Abstract][Full Text] [Related]
15. The role of risk factors for periodontal disease in patients with rheumatoid arthritis.
Gleissner C; Willershausen B; Kaesser U; Bolten WW
Eur J Med Res; 1998 Aug; 3(8):387-92. PubMed ID: 9707521
[TBL] [Abstract][Full Text] [Related]
16. Predictors of response to anti-TNF-alpha therapy among patients with rheumatoid arthritis: results from the British Society for Rheumatology Biologics Register.
Hyrich KL; Watson KD; Silman AJ; Symmons DP;
Rheumatology (Oxford); 2006 Dec; 45(12):1558-65. PubMed ID: 16705046
[TBL] [Abstract][Full Text] [Related]
17. Expression of Fcgamma and complement receptors on peripheral blood monocytes in systemic lupus erythematosus and rheumatoid arthritis.
Hepburn AL; Mason JC; Davies KA
Rheumatology (Oxford); 2004 May; 43(5):547-54. PubMed ID: 14747618
[TBL] [Abstract][Full Text] [Related]
18. Circulating levels of matrix metalloproteinases MMP-3 and MMP-1, tissue inhibitor of metalloproteinases 1 (TIMP-1), and MMP-1/TIMP-1 complex in rheumatic disease. Correlation with clinical activity of rheumatoid arthritis versus other surrogate markers.
Keyszer G; Lambiri I; Nagel R; Keysser C; Keysser M; Gromnica-Ihle E; Franz J; Burmester GR; Jung K
J Rheumatol; 1999 Feb; 26(2):251-8. PubMed ID: 9972954
[TBL] [Abstract][Full Text] [Related]
19. [Rheumatoid factors: value of their determination in patients with rheumatoid arthritis].
Ruffatti A; De Silvestro G; Meneghini P; Doria A; Pellizzaro E; Gambari PF; Todesco S
Boll Soc Ital Biol Sper; 1983 Aug; 59(8):1160-4. PubMed ID: 6354211
[TBL] [Abstract][Full Text] [Related]
20. Factors predicting response to treatment in rheumatoid arthritis: the importance of disease duration.
Anderson JJ; Wells G; Verhoeven AC; Felson DT
Arthritis Rheum; 2000 Jan; 43(1):22-9. PubMed ID: 10643696
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
